Abstract 49: Endothelial-targeted Overexpression of Heat Shock Protein 27 Ameliorates Rapid Blood Brain Barrier Impairment and Improves Long Term Outcomes After Ischemia and Reperfusion

    loading  Checking for direct PDF access through Ovid


Introduction: Blood brain barrier (BBB) damage resulting from ischemia/reperfusion (I/R) disrupts the neurovascular unit and leads to poor patient outcomes. We recently discovered that caveolin-1-independent subtle structural aberrations of brain microvascular endothelial cells (BMECs), such as abnormal actin polymerization, stress fiber formation and subsequent junctional protein (JP) disassembly, are a novel mechanism for rapid BBB breach after I/R.

Hypothesis: Heat shock protein 27 (HSP27) reduces BBB breakdown after I/R by inhibiting actin polymerization and JP disassembly in BMECs.

Methods: Neuron- or EC-specific HSP27-overexpressing mice were subjected to 1 h MCAO and reperfusion. BBB damage, tissue histology, and neurobehavioral performance were assessed up to 35 d after I/R. I/R-induced BBB damage was also simulated in BMEC cultures, where gene manipulations were achieved using lentiviral vectors. Cell-permeable TAT-HSP27 protein was injected i.v. into mice after I/R to rapidly elevate HSP27 in BMECs.

Results: Targeted overexpression of HSP27 within ECs—but not neurons—was sufficient to reduce early (1-3 h) and late (24 h) BBB damage after I/R (p<0.01). Mechanistically, HSP27 suppressed I/R-induced actin polymerization, stress fibers, and JP disassembly in BMECs, but independent of its anti-cell death properties. Intracerebral infiltration of neutrophils and macrophages was attenuated in EC-HSP27 mice by 35% and 60%, respectively (n=6, p<0.05) at 48 h after I/R. Infarct size was reduced by 35% at 72 h, and sensorimotor functions (p<0.01, cylinder and corner tests) were improved in EC-HSP27 mice up to 21 d. Post-I/R injection of TAT-HSP27 markedly reduced BBB damage and elicited sustained (up to 35 d) protection against neurological deficits.

Conclusions: HSP27 protects against BBB disruption after I/R by inhibiting actin polymerization and JP disassembly in BMECs. HSP27 may be a therapy for ischemic stroke in conjunction with reperfusion.

Related Topics

    loading  Loading Related Articles